about
Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric ResearchInvestigation of Rett syndrome using pluripotent stem cellsModeling neurodevelopmental disorders using human neuronsiPSC-derived neurons as a higher-throughput readout for autism: promises and pitfallsModelling human disease with pluripotent stem cellsA review of Rett syndrome (RTT) with induced pluripotent stem cellsUtility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological DisordersThe Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and TreatmentIsogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease modelStem cells and modeling of autism spectrum disorders.Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndromeGluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells.Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterpartsGenetic and epigenetic instability in human pluripotent stem cells.Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.Stable X chromosome reactivation in female human induced pluripotent stem cellsComparison and optimization of hiPSC forebrain cortical differentiation protocols.Systematic optimization of human pluripotent stem cells media using Design of Experiments.Single-Cell XIST Expression in Human Preimplantation Embryos and Newly Reprogrammed Female Induced Pluripotent Stem Cells.Probing disorders of the nervous system using reprogramming approaches.X-chromosome inactivation in rett syndrome human induced pluripotent stem cells.CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.Induced pluripotent stem cells to model and treat neurogenetic disordersX-chromosome inactivation in monkey embryos and pluripotent stem cellsRett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells.Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders.Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells.Cellular reprogramming: a novel tool for investigating autism spectrum disorders.Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Current status of drug screening and disease modelling in human pluripotent stem cells.In-a-dish: induced pluripotent stem cells as a novel model for human diseases.Modeling neurodevelopmental disorders using human pluripotent stem cells.Induced pluripotent stem cells for modeling of pediatric neurological disorders.Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders.Modeling autism spectrum disorders with human neurons.X chromosome inactivation in human pluripotent stem cells as a model for human development: back to the drawing board?Modeling of Autism Using Organoid Technology.Transcription factor-induced lineage programming of noradrenaline and motor neurons from embryonic stem cells.
P2860
Q26772019-CCEEEB1D-0BF2-40C6-9A4A-678ABAA80F1DQ26822991-8FDCE445-425A-4907-86B1-1FA79E3ED82BQ26825057-A6D3C097-047D-4870-98A8-ECF6147E03A8Q26827249-CB2939C5-6B68-43A5-A93A-CA97091360C1Q26864380-A9617509-58CF-40E5-B6F2-D7602FA1CF51Q28072303-0993708B-75CE-4AD6-BC9D-F985FC45488CQ28080219-F8876117-188F-425D-BEAB-A6184EE18ED9Q28081659-8BB25A93-1CDB-48EC-8CFE-B9F7A1A3872DQ28477225-BA6270BD-7676-464B-AA87-F64F620FF8E8Q30401824-E8FBC39A-26DF-4E38-9F66-37CFD4D2E5FFQ33765360-772D257E-0CDC-496D-87EE-B1FEB9681A77Q34231583-CCF29A9C-D5A3-4EEB-85C7-8807C3E40859Q34294018-4DFBBD1E-FCFB-47E3-97A2-69FF55374859Q34316491-46E15530-947A-4C81-82A7-7C4AA3F81FD4Q34845881-F5E5F833-98FF-47E5-89AF-E0023C138CBAQ35037783-FFE35E30-503C-4E56-B8B4-4FC121A3A7EBQ35075314-147A406F-09A4-4A27-9F5C-82C439205460Q35233519-00A1421F-6C29-45D5-B020-26E115C6879CQ35568999-70A5C63E-D2D4-4EB6-BAD5-260A0A6571C7Q35637909-09FC3AA9-D3A8-460E-8AAE-162A8A56B648Q35761135-EA2D9B56-D5F3-4A76-88E8-BBABA0540745Q35849292-1F904493-8C71-4D21-ABF8-DC07B98FFBE3Q36006599-9B9E76B0-8B76-4BB1-A325-F6F75B43D6A8Q36131883-6BBA8864-BB8F-47A0-8F45-B01C0862B442Q36303619-FCC506F5-6BFE-4283-80CA-6DC16BB44E1FQ36417908-134F9042-913B-425C-9503-24CD4F8F9D47Q36861726-82B58CB6-F619-4441-A4B7-AC4CB76EEAB4Q36901962-E3EB0F1B-DF08-46A9-9C1D-F6AA8FD75AFAQ37199722-CBB5CF85-D419-4926-942B-A808362744CFQ37204530-DBCEFAAF-A3FE-49EE-B138-CA2D2499D55BQ37624658-32204BE5-2818-470C-B630-4B552637FBFEQ38034129-27F61D4A-1512-492A-B7ED-1EF58ECED414Q38071032-881A4865-5634-44CC-9898-0E4DB5DD02EBQ38204302-F6013E86-15BF-4CF6-BAD2-A2965705C35AQ38212628-9149EA1A-2C68-43B2-A608-573D5DE4DE63Q38557791-B8C36547-D8AF-4246-A954-EDF9F2CB41ACQ38725769-EBCCD2B5-91A1-49E8-B1CE-7ABBD6C8DE8EQ38743213-815D9823-F022-4D2C-B2BF-866D2E359DA0Q39008875-30FF931C-53DF-4453-85B1-3DF473D32B63Q39022848-088C9782-B739-4697-874F-EE2433B8749F
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
iPS cells to model CDKL5-related disorders.
@ast
iPS cells to model CDKL5-related disorders.
@en
type
label
iPS cells to model CDKL5-related disorders.
@ast
iPS cells to model CDKL5-related disorders.
@en
prefLabel
iPS cells to model CDKL5-related disorders.
@ast
iPS cells to model CDKL5-related disorders.
@en
P2093
P2860
P50
P356
P1476
iPS cells to model CDKL5-related disorders
@en
P2093
Aaron Y L Cheung
Maria Antonietta Mencarelli
Maria Carmela Epistolato
Mariangela Amenduni
Roberta De Filippis
P2860
P2888
P304
P356
10.1038/EJHG.2011.131
P50
P577
2011-07-13T00:00:00Z